Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: Other
Life Threatening? No
Write-up: Note to MAH: Please do not return cases received from the Medicines Agency (DKMA) unless you received new information regarding the case. Please remember to use the Worldwide unique case identification number (A.1.10.1) for this case: DK-DKMA-WBS-0003221. Also, please note that information should not be deleted from the case (especially not the Patient Characteristics). Information has been received from Sanofi Pasteur MSD (SPMSD) (manufacturer control # DK-1577272925-2016004791) on 02-MAY-2016. Case received from a physician via HA on 27-Apr-2016. A 12-year-old female adolescent patient received GARDASIL (batch number Lot Not Rep) on 10-Mar-2008, GARDASIL (batch number Lot Not Rep) on 06-Jan-2009, GARDASIL (batch number Lot Not Rep) on 07-Jul-2009. The patient experienced tiredness in 2009, pain in knee in 2009, Sound sensitivity in 2010, nausea in 2011, Lower abdominal pain periodic in 2012 and Increased need of sleep in 2009. The patient had a medical history of disturbance in attention, memory impairment. The patient did not finish elementary school. Have had memory problems and problems concentrating throughout elementary school had to. Other vaccines: No. Other Medicines: No. Additional investigations included: Nuclear Magnetic Resonance Imaging n/a on an unknown date. Blood Test n/a on an unknown date. The patient''s outcome was reported as Not Recovered/Not Resolved.
Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166